Quoin Pharmaceuticals Insider Bought Shares Worth $250,000, According to a Recent SEC Filing
MT Newswires· 5 mins ago1min
Quoin Pharmaceuticals(QNRX.US)
Michael Myers, Director, Chief Executive Officer, on December 23, 2024, executed a purchase for 555,556 shares in Quoin Pharmaceuticals (QNRX) for $250,000. Following the Form 4 filing with the SEC, Myers has control over a total of 602,808 shares of the company, with 602,808 shares held directly.